Source link : https://newshealth.biz/health-news/car-t-cell-therapy-boosts-pfs-in-advanced-gastric-cancer/
TOPLINE In patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor (CAR) T-cell therapy significantly extended progression-free survival (PFS) compared with treatment of physician’s choice (TPC). METHODOLOGY CLDN18.2, a tight-junction protein, is overexpressed in patients with gastric and gastroesophageal junction (GEJ) cancers. Satri-cel, an autologous […]
The post CAR T-Cell Therapy Boosts PFS in Advanced Gastric Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-31 20:56:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8